BioSpace News Archive

– Revenue of $813.5 Million Grows 1.3%, 1.7% in Constant Currency –

Science Applications International Corporation is scheduled to issue its third quarter fiscal year 2019 results and hold a conference call after close of market on Thursday, December 6, 2018.

Glaukos Corporation today announced financial results for the third quarter ended September 30, 2018. Key highlights include:

-Strong early launch indicators for IMVEXXY™-

Fiscal 2019 First Quarter Net Sales and Adjusted Net Income Ahead of Expectations

Rêveur Corporation recorded $1,171,389 (USD$900,376) in revenue from its Adelanto operations.

Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the Company will release its financial results for the third quarter ended September 30, 2018 on Wednesday, November 14, 2018 after the close of trading

Champions Oncology, Inc. today announced that management, will participate in the 9th annual Craig-Hallum Alpha Select conference on Thursday, November 15, 2018, in New York.

Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer will present a corporate overview at the conference.

Company Also Expands Advisory Board with Two New Members